Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

EU Market Open: March 29, 2016

Published 29/03/2016, 08:50
Updated 09/07/2023, 11:32

Europe opened marginally higher with the FTSE 100 opening 0.25% up and DAX opening 0.5% up in the open thanks to mining shares opened upbeat with shares in Anglo American (LON:AAL) and Glencore (LON:GLEN) up 1%, thanks to the USD weakness seen recently. RSA Insurance (LON:RSA) rose 2.4% after Deutsche Bank (DE:DBKGn) and Barclays (LON:BARC) increased their target prices for the stock.

UK Round Up:
AstraZeneca (LON:AZN) said Japanese health authorities have approved its Tagrisso (osimertinib, AZD9291) 80mg once-daily tablets for the treatment of patients with epidermal growth factor receptor (EGFR) T790M mutation-positive inoperable or recurrent non-small cell lung cancer (NSCLC). GlaxoSmithKline (LON:GSK) announced that its Nucala (mepolizumab) has been approved by Japanese health authorities as a treatment for bronchial asthma in patients with refractory asthma whose symptoms are inadequately controlled with standard treatment.

Barr (A.G.) Plc (LON:BAG) posted FY results: Statutory profit before tax increased by 7.0% to £41.3M (2015: £38.6M) on net revenue of £258.6M (2015: £260.9M). Final dividend of 9.97p per share to give a total dividend for the full year of 13.33p per share, a full year increase of 10.0% on the prior year.

Global News
In Asia Japanese stocks edged down as weak data from the United States took some of the shine off recent evidence suggesting a reasonably healthy pulse in the world’s biggest economy – Japan’s major export market. The Nikkei index declined 0.2% to 17,106.54.

In currency markets the euro was steady at $1.1194 after gaining about 0.3% overnight to snap a six-day losing streak. Against the yen, the dollar was steady at 113.49 yen, though below its overnight high of 113.69. GBP rose after weakness from USD and is currently trading around $1.4210.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Oil prices fell in early Asian trade as concerns mount that a rally since January is fizzling out, while analysts forecast another rise to record levels for U.S. crude stockpiles. U.S. oil was down 13 cents at $39.26 a barrel, after finishing down 7 cents at $39.39, the previous session. Brent fell 16 cents to $40.11. U.S. crude oil imports are rising for the first time for more than five years, a sign that Saudi Arabia is winning its war for market share against shale producers.

In U.S. the stocks were mixed as weaker-than-expected U.S. economic data reduced concerns about potential interest rate hikes and a fall in oil prices pushed down energy stocks. The S&P 500 edged up 0.05% to 2,037.05. Starwood Hotels & Resorts Worldwide (NYSE:HOT) rose 1.97% after China’s Anbang Insurance Group Co raised its offer for the U.S. hotel operator to almost $14 billion, the latest challenge to its merger with Marriot International Inc (NASDAQ:MAR). Noble Energy (NYSE:NBL) lost 8.19% after the company warned of a possible delay in the development of a key natural gas field in Israel.

Global Market Data:
US 14:30: Feb Advance Goods Trade Balance, exp.: -$62.300B
US 14:30: Feb Personal Income, exp.: 0.1%
US 14:30: Feb Personal Spending, exp.: 0.1%
US 14:30: Feb Real Personal Spending, exp.: 0%
US 14:30: Feb PCE Deflator MoM, exp.: -0.1%
US 14:30: Feb PCE Core MoM, exp.: 0.2%
US 16:00: Feb Pending Home Sales MoM, exp.: 1.1%
US 16:30: Mar Dallas Fed Manf. Activity, exp.: -27

DISCLAIMER: The above is not considered financial advice or any endorsement to use any particular service. If you wish to use any of the services mentioned, please seek independent advice.

RISK WARNING: Spread betting, CFD, futures and options trading carries a high level of risk to your capital and can result in losses that exceed your initial deposit. They may not be suitable for everyone, so please ensure that you fully understand the risks involved. Past performance of a managed service is not a guide to future performance.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.